Cargando…
Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment
Autores principales: | Fenton, Fiona, Stokes, Siobhan, Eagleton, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390020/ https://www.ncbi.nlm.nih.gov/pubmed/34436756 http://dx.doi.org/10.1007/s11845-021-02742-9 |
Ejemplares similares
-
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment
por: Fenton, Fiona, et al.
Publicado: (2021) -
Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382–3
por: Eagleton, Marie, et al.
Publicado: (2021) -
Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection
por: Eagleton, Marie, et al.
Publicado: (2021) -
Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
por: Konu, Yao Rodion, et al.
Publicado: (2023) -
Expansion of opiate agonist treatment: an historical perspective
por: Newman, Robert G
Publicado: (2006)